Genomics Market Size, Share, Trends & Competitive Analysis By Type (Genomic Sequencing, Genomic Microarrays, Polymerase Chain Reaction, Next-Generation Sequencing, Genomic Editing) By Application: By Technology: By End-user: By Regions, and Industry Forecast, Global Report 2023-2030

  • Report ID: FDS594
  • Forecast Period: 2023-2030
  • No. of Pages: 150+
  • Industry: Biotechnology

The global Genomics market size was valued at USD 33.40 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 15.2% during the forecast period, reaching a value of USD 95.20 billion by 2030.

Genomics market research report by Future Data Stats, offers a comprehensive view of the market's historical data from 2018 to 2021, capturing trends, growth patterns, and key drivers. It establishes 2022 as the base year, analyzing the market landscape, consumer behavior, competition, and regulations. Additionally, the report presents a well-researched forecast period from 2023 to 2030, leveraging data analysis techniques to project the market's growth trajectory, emerging opportunities, and anticipated challenges.


Genomics is a branch of molecular biology and genetics that focuses on the study of an organism's entire set of genes, known as its genome. It encompasses the comprehensive analysis of an individual's genetic material, including DNA and RNA, with the aim of understanding the structure, function, and regulation of genes. Genomics explores the genetic information encoded in an organism's DNA, providing insights into various aspects such as an individual's susceptibility to diseases, genetic variations, and the potential for personalized medicine. It plays a crucial role in fields like healthcare, agriculture, and biotechnology by unraveling the genetic basis of traits, diseases, and biological processes, facilitating advancements in diagnostics, therapeutics, and genetic research.


The primary drivers being the increasing demand for personalized medicine and precision healthcare. Genomics enables the identification of individual genetic variations, allowing healthcare providers to tailor treatments based on a patient's genetic profile. This shift towards precision medicine is revolutionizing healthcare, driving the adoption of genomics technologies. Additionally, research and development in genomics are contributing to advancements in drug discovery and development, further fueling market growth. Moreover, the declining cost of genomic sequencing and technological innovations have made genomics more accessible, attracting both research institutions and healthcare providers.

However, the Genomics market also faces several restraints, including concerns related to data privacy and ethical considerations. As the volume of genomic data collected and analyzed grows, safeguarding this sensitive information becomes paramount. Ensuring data security and adhering to ethical guidelines are significant challenges. Moreover, the interpretation of complex genomic data remains a challenge, particularly in the clinical setting. Healthcare professionals need robust tools and training to effectively utilize genomics information for patient care. Despite these challenges, opportunities abound in the Genomics market, particularly in emerging economies and the integration of genomics into mainstream healthcare practices. The ongoing quest to unravel the complexities of the human genome continues to drive innovation, promising exciting prospects for personalized medicine, disease prevention, and improved healthcare outcomes.



Genomic Sequencing is a pivotal segment, representing the cornerstone of genomics research and applications. It involves the determination of the exact order of nucleotides within an organism's DNA, offering invaluable insights into genetic variations and potential links to diseases. This foundational technology is indispensable in fields like precision medicine, personalized genomics, and genetics research.

Genomic Microarrays also play a significant role in the market. These arrays enable the simultaneous analysis of thousands to millions of DNA sequences, allowing for the detection of genetic variations, gene expression patterns, and genomic imbalances. Genomic Microarrays are widely employed in genotyping studies, cancer research, and diagnostics, contributing to their dominance in the genomics landscape. Polymerase Chain Reaction (PCR) is another pivotal technology in the Genomics market. PCR amplifies specific DNA sequences, facilitating their analysis and detection. It plays a crucial role in genomics applications, such as DNA sequencing preparation, genetic testing, and gene expression profiling. The versatility and efficiency of PCR technology make it a dominant factor in genomics research and diagnostics.

Next-Generation Sequencing (NGS) represents a revolutionary advancement in genomics. It enables the rapid and cost-effective sequencing of entire genomes, transcriptomes, and exomes, fostering the exploration of genetic diversity and disease-related mutations. NGS has become a dominant force in genomics research, enabling large-scale genomic studies, uncovering rare genetic variants, and driving progress in fields like cancer genomics and rare disease diagnostics. Genomic Editing, including technologies like CRISPR-Cas9, is emerging as a dominant factor in the Genomics market. It allows for precise modification of DNA sequences, offering the potential to correct genetic mutations and develop innovative therapies. Genomic Editing is increasingly important in gene therapy, genetic research, and biotechnology applications, shaping the future of genomics.


Personalized Medicine is a dominant application, capitalizing on genomic data to tailor medical treatments to an individual's genetic makeup. This approach enhances treatment efficacy, reduces adverse reactions, and optimizes patient outcomes. As healthcare shifts towards precision medicine, the demand for genomics-based diagnostics and therapeutics continues to rise, making Personalized Medicine a major force in the Genomics market.

Oncology represents another influential segment in the Genomics market, fueled by the quest to better understand cancer's genetic underpinnings. Genomic studies in oncology help identify cancer-related mutations, predict disease progression, and guide treatment decisions. Advancements in cancer genomics have led to targeted therapies and immunotherapies, significantly improving cancer care and making Oncology a dominant application within the Genomics market.

Genetic Testing is a pivotal factor, encompassing a wide range of tests designed to detect genetic variations associated with diseases and conditions. The increasing awareness of genetic risk factors and the growing availability of direct-to-consumer genetic testing kits have driven consumer interest in genetic testing services. The potential to uncover ancestry, health predispositions, and carrier status for genetic disorders has contributed to the prominence of Genetic Testing in the Genomics market.

Agriculture is a key application, where genomics is harnessed to improve crop yields, disease resistance, and livestock genetics. Genomic data assists in breeding programs, allowing for the selection of traits that enhance agricultural productivity and sustainability. As global food demand increases, the integration of genomics into agriculture becomes a dominant factor in meeting these challenges. Pharmacogenomics, the study of how an individual's genetic makeup influences their response to drugs, is also shaping the Genomics market. By tailoring medication choices and dosages to a patient's genetic profile, pharmacogenomics enhances drug safety and efficacy, demonstrating the potential to revolutionize healthcare practices.


DNA Sequencing stands out as a dominant technology, enabling the determination of the precise sequence of nucleotides in an organism's DNA. It plays a foundational role in genomics research, diagnostics, and personalized medicine. Advances in DNA Sequencing technologies have led to increased sequencing speed and reduced costs, making it a driving force in the Genomics market. RNA Sequencing (RNA-Seq) is another influential factor, offering insights into gene expression and regulation. This technology allows researchers to examine the transcriptome, providing a deeper understanding of how genes are actively expressed and controlled. RNA-Seq's ability to capture dynamic changes in gene expression has propelled its prominence in genomics research, particularly in fields like cancer biology and developmental biology.

Genotyping is a dominant technology within the Genomics market, focusing on the identification of genetic variations, including single nucleotide polymorphisms (SNPs) and insertions/deletions. Genotyping is widely used in population genetics studies, disease association studies, and personalized genomics. Its applications in ancestry testing and genetic risk assessment have made it a key player in the genomics landscape. Gene Expression Profiling is pivotal in understanding the complex regulatory mechanisms that govern gene activity. This technology provides insights into how genes are turned on or off in response to various stimuli or conditions.


Research Institutes stand as a dominant end-user segment, as they play a pivotal role in advancing genomics research. These institutions drive innovation, conduct fundamental genomic studies, and pioneer breakthroughs in understanding the human genome and other organisms, shaping the landscape of genomics research.

Biotechnology Companies are a significant force in the Genomics market, leveraging genomic data for drug discovery, development, and biotechnology applications. Genomics provides valuable insights into disease mechanisms, target identification, and biomarker discovery, empowering biotech companies to create innovative therapies and products. Their ability to bridge the gap between research and commercialization makes them key players in the genomics industry.

Pharmaceutical Companies are also dominant end-users, incorporating genomics into drug development pipelines. Genomic data helps pharmaceutical companies identify drug targets, predict patient responses, and personalize treatments. As the industry increasingly embraces precision medicine, pharmaceutical companies continue to drive the integration of genomics into healthcare, impacting patient care and outcomes.

Diagnostic Laboratories represent a crucial segment within the Genomics market, offering genetic testing services and diagnostic solutions. They provide services ranging from carrier screening to disease risk assessment, and their role in translating genomics into actionable insights for healthcare professionals and patients is significant. As genetic testing becomes more accessible and routine in clinical practice, diagnostic laboratories remain a driving force in the genomics landscape.


North America remains a dominant force in this industry, driven by robust investments in genomics research, well-established healthcare infrastructure, and a thriving biotechnology sector. The region benefits from a supportive regulatory environment and a strong presence of pharmaceutical companies, making it a hotbed for genomic innovations. The United States, in particular, hosts numerous genomics-focused companies and research institutions, contributing significantly to market growth.

Europe also plays a prominent role, with a strong emphasis on research and development in genomics and personalized medicine. The region is characterized by collaborative genomics initiatives, such as the UK Biobank and various EU-funded projects, fostering advancements in genomic research and healthcare applications. Additionally, Europe boasts a growing genomics diagnostics sector, with an increasing number of clinical laboratories offering genetic testing services.

The Asia Pacific is an emerging powerhouse, driven by the region's rapid economic growth, expanding healthcare infrastructure, and increasing adoption of genomics technologies. Countries like Japan and South Korea are at the forefront of genomics research and diagnostics, with a focus on precision medicine. China's genomics industry has also witnessed remarkable growth, with investments in large-scale genomics projects and biotechnology startups. Latin America, the Middle East, and Africa, while emerging, are showing increasing interest in genomics research and applications, particularly in the fields of agriculture and healthcare.


On one hand, the pandemic underscored the importance of genomics in understanding and combatting infectious diseases. Genomic sequencing played a crucial role in identifying and tracking new variants of the SARS-CoV-2 virus, aiding in the development of vaccines and treatments. The pandemic accelerated genomics research related to virology and immunology, highlighting its significance in public health.

However, the pandemic also posed certain challenges to the Genomics market. Supply chain disruptions, particularly in the early stages of the pandemic, impacted the availability of reagents and sequencing equipment, hindering research and diagnostics. Additionally, the shift in healthcare resources towards COVID-19 response temporarily diverted attention and funding from other genomics projects. Clinical trials and research projects were delayed or reshaped to accommodate pandemic-related priorities.


Mergers & Acquisitions:

  • In 2023, Illumina acquired Grail, a cancer detection company, for $8 billion.
  • In 2023, Thermo Fisher Scientific acquired Affymetrix, a gene sequencing company, for $1.3 billion.
  • In 2022, Danaher acquired Cytiva, a life sciences company, for $21.4 billion.

Product New Launches:

  • In 2023, Illumina launched the NovaSeq X Plus, a new gene sequencer that can generate up to 600 terabytes of data per day.
  • In 2023, PacBio launched the Sequel IIe, a new gene sequencer that can generate long reads of up to 100,000 base pairs.
  • In 2022, Oxford Nanopore Technologies launched the PromethION 2, a new gene sequencer that can generate reads of up to 2 million base pairs.


  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • F. Hoffmann-La Roche AG
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Ltd.
  • BGI Genomics Co., Ltd.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Eurofins Scientific SE
  • Myriad Genetics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • GE Healthcare
  • GenScript Biotech Corporation
  • Natera, Inc.
  • Macrogen, Inc.
  • 10x Genomics, Inc.
  • Veracyte, Inc.
  • Helix OpCo LLC
  • Invitae Corporation
  • Fluidigm Corporation
  • Genomic Health, Inc.
  • Genewiz
  • Partek Incorporated
  • others

Table of Contents

  1. Introduction
  2. Executive Summary
  3. Market Overview
  4. Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
    • Challenges
  5. Genomics Market Segmentation
    • By Type
    • By Application
    • By Technology
    • By End-user
    • By Region
  6. Competitive Landscape
    • Key Players
    • Market Share Analysis
    • Competitive Strategies
  7. Genomic Sequencing
    • Techniques and Technologies
    • Market Trends
    • Applications
  8. Genomic Microarrays
    • Techniques and Technologies
    • Market Trends
    • Applications
  9. Polymerase Chain Reaction (PCR) in Genomics
    • Techniques and Technologies
    • Market Trends
    • Applications
  10. Next-Generation Sequencing (NGS)
  • Techniques and Technologies
  • Market Trends
  • Applications
  1. Genomic Editing
  • Techniques and Technologies
  • Market Trends
  • Applications
  1. Genomics in Personalized Medicine
  • Advancements and Impact
  • Case Studies
  1. Genomics in Oncology
  • Advances in Cancer Genomics
  • Case Studies
  1. Genetic Testing
  • Types of Genetic Tests
  • Market Trends
  • Applications
  1. Genomics in Agriculture
  • Crop Improvement
  • Livestock Genetics
  1. Pharmacogenomics
  • Drug Development and Personalized Medicine
  • Case Studies
  1. Research Institutes in Genomics
  • Contributions and Initiatives
  1. Biotechnology Companies in Genomics
  • Innovations and Market Presence
  1. Pharmaceutical Companies in Genomics
  • Drug Discovery and Development
  1. Diagnostic Laboratories in Genomics
  • Testing Services and Market Trends
  1. Genomics Market by Region
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  1. Future Outlook and Projections
  2. Conclusion
  3. References

Genomics Market Segmentation

By Type:

  • Genomic Sequencing
  • Genomic Microarrays
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Genomic Editing

By Application:

  • Personalized Medicine
  • Oncology
  • Genetic Testing
  • Agriculture
  • Pharmacogenomics

By Technology:

  • DNA Sequencing
  • RNA Sequencing
  • Genotyping
  • Gene Expression Profiling

By End-user:

  • Research Institutes
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Diagnostic Laboratories


By Geography:

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Reasons to Purchase this Report

  • Comprehensive Insights: Our market research reports offer in-depth and comprehensive insights into various industries, markets, and sectors. These reports are the result of meticulous data collection, rigorous analysis, and expert interpretation. They provide you with invaluable information and a clear understanding of market trends, dynamics, and opportunities.
  • Future Predictions: Our reports include future data statistics, forecasts, and predictions that are based on thorough analysis and modeling techniques. We consider factors such as market growth drivers, challenges, and emerging trends. Accessing these future data stats empowers you to make informed decisions and formulate strategies aligned with projected market scenarios.
  • Industry Analysis: Our reports provide detailed industry analysis, encompassing critical factors like market size, market share, competitive landscape, and key players. They furnish an overview of the industry's current status, growth potential, and competitive dynamics. This knowledge enables you to pinpoint lucrative opportunities and maintain a competitive edge.
  • Market Trends and Opportunities: By acquiring our market research reports, you gain access to up-to-the-minute information on market trends and emerging opportunities. These reports shed light on the latest consumer preferences, technological advancements, regulatory changes, and other influential factors shaping the market landscape. Tracking these trends equips you to identify potential growth areas and adapt your business strategies accordingly.
  • Risk Mitigation: Investing in our market research reports can serve as a risk mitigation strategy in the face of market uncertainties. Our reports offer insights into potential risks, challenges, and barriers to entry in specific markets or industries. Armed with this knowledge, you can devise risk mitigation strategies, anticipate market fluctuations, and make informed decisions to minimize potential losses.
  • Investment Decision Support: Our market research reports are invaluable tools for investors, venture capitalists, and financial institutions. They provide reliable, data-driven information that aids investment decision-making processes. By scrutinizing these reports, investors can assess market potential, evaluate investment opportunities, and gauge expected returns.
  • Product Development and Innovation: Our reports offer insights into consumer preferences, needs, and demands, which can be leveraged for product development and innovation. Understanding market dynamics and consumer behavior allows you to tailor your products or services to meet evolving customer needs, leading to enhanced customer satisfaction and market success.
  • Strategic Planning: Our market research reports serve as the foundation for strategic planning. They furnish a comprehensive overview of the market landscape, competitive positioning, and growth potential. Armed with this knowledge, you can formulate effective business strategies, set realistic goals, and allocate resources efficiently. Strategic planning based on accurate market research optimizes your operations and enhances your chances of success.
  • Market Entry and Expansion: For businesses eyeing new markets or looking to expand, our market research reports are indispensable. These reports provide insights into market dynamics, consumer behavior, regulatory frameworks, and competitive landscapes specific to target markets. This information helps you assess market entry feasibility, identify potential obstacles, and devise market entry strategies for increased success.
  • Evidence-Based Decision Making: Our market research reports offer evidence-based data and analysis, allowing for informed decision making. Rather than relying on assumptions or guesswork, you can base your decisions on reliable information and market insights. Evidence-based decision making reduces the risk of costly mistakes and heightens the likelihood of achieving your business objectives.


With a collective industry experience of about 70 years of analysts and experts, Future Data Stats encompasses the most infallible research methodology for its market intelligence and industry analysis. Not only does the company dig deep into the innermost levels of the market, but also examines the minutest details for its market estimates and forecasts.

This approach helps build a greater market-specific view of size, shape, and industry trends within each industry segment. Various industry trends and real-time developments are factored into identifying key growth factors and the future course of the market. The research proceeds are the results of high-quality data, expert views & analysis, and valuable independent opinions. The research process is designed to deliver a balanced view of the global markets and allows stakeholders to make informed decisions, to attain their highest growth objectives.

Future Data Stats offers its clients exhaustive research and analysis, based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models distill the data & statistics and enhance the accuracy of our recommendations and advice.

With Future Data Stats calibrated research process and 360° data-evaluation methodology, the clients receive:

  • Consistent, valuable, robust, and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through a well-audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of the marketplace

With this strong methodology, Future Data Stats ensures that its research and analysis is most reliable and guarantees sound business planning.

The research methodology of the global market involves extensive primary and secondary research. Primary research includes about 24 hours of interviews and discussions with a wide range of stakeholders that include upstream and downstream participants. Primary research typically is a bulk of our research efforts, coherently supported by extensive secondary research. Over 3000 product literature, industry releases, annual reports, and other such documents of key industry participants have been reviewed to obtain a better market understanding and gain enhanced competitive intelligence. In addition, authentic industry journals, trade associations’ releases, and government websites have also been reviewed to generate high-value industry insights.

Primary Research:

Primary Research


Desk Research


Company Analysis


•       Identify key opinion leaders

•       Questionnaire design

•       In-depth Interviews

•       Coverage across the value chain


•       Company Website

•       Company Annual Reports

•       Paid Databases

•       Financial Reports


•       Market Participants

•       Key Strengths

•       Product Portfolio

•       Mapping as per Value Chain

•       Key focus segment


Primary research efforts include reaching out to participants through emails, telephonic conversations, referrals, and professional corporate relations with various companies that make way for greater flexibility in reaching out to industry participants and commentators for interviews and discussions.

The aforementioned helps to:

  • Validate and improve data quality and strengthen the research proceeds
  • Develop a market understanding and expertise
  • Supply authentic information about the market size, share, growth, and forecasts

The primary research interview and discussion panels comprise experienced industry personnel.

These participants include, but are not limited to:

  • Chief executives and VPs of leading corporations specific to an industry
  • Product and sales managers or country heads; channel partners & top-level distributors; banking, investments, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research:

A broad array of industry sources for the secondary research typically includes, but is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor  presentations for a competitive scenario and shape of the industry
  • Patent and regulatory databases to understand technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles, web-casts, and other related releases to evaluate the market
  • Internal and external proprietary databases, key market indicators, and relevant press releases for  market estimates and forecasts



•       Top executives of end-use industries

•       C-level executives of the leading Parenteral Nutrition companies

•       Sales manager and regional sales manager of the Parenteral Nutrition companies

•       Industry Consultants

•       Distributors/Suppliers


•       Annual Reports

•       Presentations

•       Company Websites

•       Press Releases

•       News Articles

•       Government Agencies’ Publications

•       Industry Publications

•       Paid Databases


Analyst Tools and Models:



·         Arriving at
Global Market Size

·         Arriving at
Market Size

·         Market Share
of Key Players

·         Key Market Players

·         Key Market Players

·         Market Share
of Key Players

·         Arriving at
Market Size

·         Arriving at
Global Market Size


Genomics Market Dynamic Factors


  • Advancements in genomic technologies and sequencing methods
  • Growing demand for personalized medicine and precision healthcare
  • Increased awareness of genetic contributions to diseases
  • Expanding applications in diagnostics, therapeutics, and research
  • Rising investments in genomics research and infrastructure
  • Integration of genomics into drug discovery and development
  • Growing adoption of genomics in agriculture and livestock breeding


  • High costs associated with genomic sequencing and analysis
  • Ethical and privacy concerns related to genetic data
  • Limited reimbursement policies for genomic tests
  • Variability in data interpretation and clinical utility
  • Regulatory complexities and compliance challenges
  • Shortage of skilled professionals in genomics
  • Inequities in access to genomic healthcare


  • Development of more cost-effective sequencing technologies
  • Expansion of genomic applications in rare diseases and cancer
  • Increased use of genomics in infectious disease surveillance
  • Advancements in CRISPR-Cas9 and gene editing technologies
  • Growth potential in emerging markets and telemedicine
  • Integration of genomics into mainstream healthcare
  • Collaborations and partnerships between academia and industry


  • Ethical dilemmas in genome editing and designer babies
  • Ensuring data security and patient privacy
  • Standardization of genomic data formats and protocols
  • Interpretation of complex genomic data
  • Bridging the gap between genomics research and clinical practice
  • Addressing disparities in genomic healthcare access
  • Managing the volume and diversity of genomic data

Frequently Asked Questions

The global Genomics market size was valued at USD 33.40 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 15.2% during the forecast period, reaching a value of USD 95.20 billion by 2030.

Key growth factors include advancements in genomics technologies, rising demand for personalized medicine, increased awareness of genetic contributions to diseases, and growing investments in genomics research and infrastructure.

Current trends in the Genomics market include the development of more cost-effective sequencing technologies, the expansion of genomics applications in rare diseases and cancer, and the integration of genomics into drug discovery and development. Advancements in gene editing technologies like CRISPR-Cas9 are also notable.

North America, Europe, and parts of Asia-Pacific, including Japan and South Korea, are expected to dominate the Genomics market due to strong investments in research and well-established healthcare infrastructure.

Major challenges include ethical dilemmas in genome editing, ensuring data security and patient privacy, and bridging the gap between genomics research and clinical practice. Opportunities lie in expanding genomics applications in emerging markets, telemedicine, and collaborations between academia and industry.
Why Future Data Stats?
Examine Of Marketplace

Your Commercial Enterprise Can Develop Primarily Based On Exclusive Research Results, Along Side Insightful Services. It's Going To Also Allow You To Recognize Diverse Marketing Updates And Different Brand In A Extra Efficient Way.

1+ Million Marketplace Research Report

we performs all the essential studies and provide commonly accurate, result oriented income statistics, market facts, and data marketplace scenarios of the past and future. with experience of over 10 years our research report library cover collection of one million plus reports.

Prediction about the Worldwide Marketplace

so as to gain information on the worldwide markets future data stats offer most correct market prediction using both pessimistic view to benefit truthful concept of future development.

Traditional and Hybrid Methodologies

future data stats presents a holistic and extra accurate view of the marketplace through a aggregate of secondary and primary research and hybrid methodologies.